BIRMINGHAM, AL

UNIVERSITY OF ALABAMA AT BIRMINGHAM

Grant: $365,833 - National Institutes of Health - May. 21, 2009

Are you satisfied with this award? or

No votes have been cast for this award yet

Join the conversation: Post a comment about this award


Award Description: During aging, an increasing proportion of total lens proteins becomes water insoluble (WI) either due to aggregation and/or cross-linking. The increased sizes of cross-linked multimers of crystallins become so large that they finally become water insoluble and cause lens opacity during age-related (senile) cataract development. Among the variety of post-translational modifications, deamidation and truncations of crystallins are identified as the most abundant during aging in human lenses. Therefore, these modifications play a major role in age-related aggregation and cross-linking of crystallins, and in turn, are significant causative factors in age-related cataract development. Our studies have shown that ßA3-crystallin exists as an activable proteinase in the lens, and the active enzyme is capable of proteolyzing alpha A-, alpha B-, gamma C- and gamma D-crystallins. Further, our studies demonstrated that ßA3 proteinase is inhibition by alpha A- and alpha B-crystallins. Based on these results, we have hypothesized that ßA3-proteinase activity is regulated in vivo by alpha A- and alpha B-crystallins as inhibitors, and the activated ßA3-proteinase proteolyzes alpha-, beta- and gamma-crystallins. The crystallin fragments per se aggregate and/or undergo post-translational modifications such as deamidation. The unmodified and modified crystallin fragments aggregate and cross-link with intact crystallins to first form the water soluble-high molecular weight (WS-HMW) proteins, where its components cross-link and become water insoluble. To test the above hypothesis, the proposed studies will be focused to answer the following two questions: (1) Which polypeptide (amino acids) forms the beta A3 proteinase active site, and how is the proteinase activity inhibited by alpha A- and alpha B-crystallins? (2) What are the roles of crystallin fragments and/or deamidated crystallins in aggregation and cross-linking processes of crystallins in vivo? To answer the first question, we will determine the beta A3-proteinase active site in the regions of the motifs III and IV, the proteinase-induced proteolysis of alpha-, beta- and gamma-crystallins in vivo, and the inhibition mechanism of beta A3-proteinase by alpha A and alpha B-crystallins. To answer the second question, we will determine whether the fragments of alpha-, beta-, and gamma-crystallins are post-translationally modified in vivo during aging and cataract development, the mechanism of complex formation between crystallin fragments and deamidated crystallins, and effects of deamidation of Asn(s) in alphaA- and alpha B-crystallins on lens transparency using transgenic mouse models. Because human lenses will be used in these studies, the findings will be relevant in elucidation of in vivo properties of ßA3-proteinase, its regulation by alpah A- and alpha B-crystallins as inhibitors, the ßA3-proteinase-induced proteolysis of crystallins, and potential roles of protelyzed crystallin fragments and their deamidated species in aggregation and cross-linking process during development of opacity in aging human lenses.

Project Description: Same as award description

Jobs Summary: Jobs or positions retained:Faculty Researcher, Non-faculty Researcher, Student Researcher (Total jobs reported: 2)

Project Status: Less Than 50% Completed

This award's data was last updated on May. 21, 2009. Help expand these official descriptions using the wiki below.


Funds Recipient

UNIVERSITY OF ALABAMA AT BIRMINGHAM
BHAM, AL 35294
See more awards to this recipient

Place of Performance

1530 Third Avenue South
BIRMINGHAM, AL 35294
See more awards in this zip code



Wiki Description

No comments have been added for this project.

Edit the Wiki Description (editing policy)


Post a comment